{
  "scenario_id": "quantum_algorithm_development_investment_decision_2025",
  "context": "Major pharmaceutical company investing in quantum algorithm development for molecular simulation and drug discovery acceleration",
  "stakeholders": {
    "requester": "Chief Scientific Officer",
    "approvers": [
      "Chief Executive Officer",
      "Chief Financial Officer",
      "Board Innovation Committee"
    ],
    "influencers": [
      "Computational Chemistry Team",
      "Drug Discovery Leadership",
      "Academic Research Partners"
    ]
  },
  "request": {
    "amount": "$15,000,000",
    "purpose": "Develop proprietary quantum algorithms for molecular modeling and drug discovery",
    "urgency": "medium",
    "justification": "Accelerate drug discovery timelines and improve molecular prediction accuracy beyond classical methods"
  },
  "decision_process": [
    {
      "stage": "scientific_feasibility_study",
      "duration": "3 months",
      "activities": [
        "Quantum chemistry analysis",
        "Algorithm design exploration",
        "Performance benchmarking"
      ],
      "outcome": "Demonstrated quantum advantage in molecular energy calculations with 1000x speedup potential"
    },
    {
      "stage": "team_formation",
      "duration": "1 month",
      "activities": [
        "Expert recruitment",
        "Partnership establishment",
        "Resource allocation"
      ],
      "outcome": "Cross-functional quantum chemistry team assembled with academic and industry expertise"
    },
    {
      "stage": "algorithm_development_planning",
      "duration": "2 months",
      "activities": [
        "Research roadmap creation",
        "Milestone definition",
        "IP strategy development"
      ],
      "outcome": "Comprehensive development plan with quarterly milestones and patent protection strategy"
    },
    {
      "stage": "funding_commitment",
      "duration": "1 month",
      "activities": [
        "Budget approval process",
        "ROI modeling",
        "Risk mitigation planning"
      ],
      "outcome": "Full funding approved with performance-based milestone payments"
    }
  ],
  "business_impact": {
    "expected_benefits": [
      "Accelerated drug discovery",
      "Improved molecular prediction accuracy",
      "Proprietary quantum IP portfolio"
    ],
    "projected_revenue": "Expected $200M in accelerated drug development savings and new compound revenues",
    "risk_factors": [
      "Algorithm development challenges",
      "Hardware access limitations",
      "Integration with existing workflows"
    ]
  }
}
